• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SCYNEXIS, Inc. - Common Stock (NQ:SCYX)

0.8137 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.8137
Bid (Size) 0.8113 (2,400)
Ask (Size) 0.8500 (3,800)
Prev. Close 0.8137
Today's Range 0.8137 - 0.8137
52wk Range 0.5650 - 1.310
Shares Outstanding 37,175,665
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 20, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
October 02, 2025
 
Via Benzinga

Performance

YTD
+27.4%
+27.4%
1 Month
+26.6%
+26.6%
3 Month
+37.9%
+37.9%
6 Month
-0.8%
-0.8%
1 Year
-24.0%
-24.0%

More News

Read More
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
September 30, 2025
Via Benzinga
News headline image
Here are the top movers in Tuesday's session. ↗
September 30, 2025
Via Chartmill
News headline image
Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing? ↗
May 20, 2024
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
September 30, 2025
Via Benzinga
News headline image
These stocks are moving in today's session ↗
September 30, 2025
Via Chartmill
News headline image
Tuesday's session: gap up and gap down stocks ↗
September 30, 2025
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
September 30, 2025
Via Chartmill
News headline image
The market is filled with gapping stocks in Friday's session. ↗
May 16, 2025
Via Chartmill
News headline image
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024 ↗
August 09, 2024
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
July 23, 2024
Via InvestorPlace
News headline image
3 Stocks Under $10 With the Potential for Massive Gains ↗
July 22, 2024
Via InvestorPlace
News headline image
3 Dirt-Cheap Drug Developers With Blockbuster Potential ↗
July 11, 2024
Via InvestorPlace
News headline image
7 Undervalued Biotech Stocks to Buy for Big-Time Returns ↗
July 01, 2024
Via InvestorPlace
News headline image
Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025 ↗
May 31, 2024
Via InvestorPlace
News headline image
3 Stocks Under $10 With Mammoth Growth Prospects ↗
May 23, 2024
Via InvestorPlace
News headline image
SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024 ↗
May 08, 2024
Via InvestorPlace
News headline image
SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023 ↗
March 28, 2024
Via InvestorPlace
News headline image
5 Value Stocks To Watch In The Healthcare Sector ↗
January 29, 2024
Via Benzinga
SCYX DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages SCYNEXIS, Inc. Investors with Losses to Secure Counsel Before Important January 8 Deadline in Securities Class Action - SCYX
January 08, 2024
Via NewMediaWire
Topics Lawsuit Product Recall
News headline image
A Look Into Healthcare Sector Value Stocks ↗
January 08, 2024
Via Benzinga
News headline image
SCYX DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important January 8 Deadline in Securities Class Action – SCYX
January 06, 2024
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
SCYNEXIS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SCYNEXIS, Inc. and Encourages Investors to Contact the Firm
January 05, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
SCYNEXIS SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
January 05, 2024
From Faruqi & Faruqi LLP
Via GlobeNewswire

Frequently Asked Questions

Is SCYNEXIS, Inc. - Common Stock publicly traded?
Yes, SCYNEXIS, Inc. - Common Stock is publicly traded.
What exchange does SCYNEXIS, Inc. - Common Stock trade on?
SCYNEXIS, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for SCYNEXIS, Inc. - Common Stock?
The ticker symbol for SCYNEXIS, Inc. - Common Stock is SCYX on the Nasdaq Stock Market
What is the current price of SCYNEXIS, Inc. - Common Stock?
The current price of SCYNEXIS, Inc. - Common Stock is 0.8137
When was SCYNEXIS, Inc. - Common Stock last traded?
The last trade of SCYNEXIS, Inc. - Common Stock was at 02/18/26 04:00 PM ET
What is the market capitalization of SCYNEXIS, Inc. - Common Stock?
The market capitalization of SCYNEXIS, Inc. - Common Stock is 30.25M
How many shares of SCYNEXIS, Inc. - Common Stock are outstanding?
SCYNEXIS, Inc. - Common Stock has 30M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap